Well, Robert, today I kind of figured out something that is very thematic with any legislation is that we kind of take the good with the bad, thats never black and white, that we could always do better
Compared with the low-risk group, the high-risk group had higher rejection scores but significantly lower dysfunction scores, suggesting that the high-risk group was more likely to have T cell depletion than the low-risk group, while the low-risk group was more likely to have immune cell dysfunction
Do we want to control this situation ourselves and with the help of physicians who have experience with ketogenic therapy, or rely on the physicians who prescribed the medications and the pharmaceutical industry
Originally developed for treatment of Type 2 diabetes (T2D), many patients reported appetite and weight reductions, and utilization soon skyrocketed for people with and without T2D
10.1021/acsami.6b11136 17 CostaO
doi: 10.1016/j.kint.2024.01.040 50 LeeH.LiuX.AnJ